Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07014293 · ClinicalTrials.gov registry record · NA
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
A NA study, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT07014293: Recruiting NA study, sponsored by Massachusetts General Hospital.
NCT07014293 is a NA study that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 254 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07014293, a NA study, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.
Interventions
- OTHER Enhanced Usual Care
- OTHER SMART3RP-Lymphoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2030-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07014293
The ClinicalTrials.gov registry entry for NCT07014293 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT07014293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07014293 about?
NCT07014293 is a clinical study titled "Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors". The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.
What is the current status of trial NCT07014293?
This trial is currently recruiting. It is a NA study. The enrollment target is 254 participants. The study started on 2026-07-01. Estimated completion is 2030-07-01.
What interventions are being tested in trial NCT07014293?
The interventions under investigation include: Enhanced Usual Care (OTHER), SMART3RP-Lymphoma (OTHER).
Who is sponsoring clinical trial NCT07014293?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.